It is sometimes good to remind new readers of what is meant

New Post Public Reply Private Reply Replies (0) Message Board
Haschwald_Zimmer Drano #30238
401
It is sometimes good to remind new readers of what is meant by “bullish slant” as mentioned in the sticky on this board. It also helps to define the characteristics of “bashers” guilty of “embedded deception” whom are deserving of karmic justice and life in prison. Their traits are as follows:

Praising the rapid pace of Prurisol 2B
http://investorshangout.com/post/view?id=4271552

Repeated B-OM bullishness
http://investorshangout.com/post/view?id=4275666

Repeated faith in a partnership/buyout
http://investorshangout.com/post/view?id=4276858

Supporting the biggest pumper on the board regarding the low market cap of the company
http://investorshangout.com/post/view?id=4277304

Valuing the company at 2-3 billion ($15+/share) in the next 12-24 months
http://investorshangout.com/post/view?id=4280122

Asking for $20-30/share in 2017
http://investorshangout.com/post/view?id=4280731

Calling out Ihub's misdeeds
http://investorshangout.com/post/view?id=4282726

Anticipating deals with upfront payments of at least $50M
http://investorshangout.com/post/view?id=4283265

Belief in a high probability of a partnership/deal within the next 12-15 months
http://investorshangout.com/post/view?id=4285027

Truly, with these traits as a back drop it is easy to see that discussion of funding and deal-making time lines is deception of the most embedded nature. Thankfully there are many faithful sentries of this board willing to call these villainous sociopaths to task.

I'll end the sarcasm with that. The scum are at Ihub. There are no paid bashers here...just people who aren't on their fourth cup of Koolaid...or is that the fourth cup of Red Bullish Slant?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.

Current Positions:
Long CTIX.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Yoshiharu Global's Stock Struggles Amid Market Fluctuations

Updated Category News Views 101

Yoshiharu Global Stock Faces Major Challenges Yoshiharu Global Co. is currently navigating through turbulent waters, as evidenced by the stock reaching a concerning 52-week low of $2.7. This decline starkly contrasts its previous performance, revealing a significant drop of 43.1% in value over the past year. Investors are reflecting on the broader market conditions and...

Continue Reading
Investors Alert: Class Action Against Nextracker Inc. Uncovered

Updated Category News Views 172

Class Action Lawsuit Filed Against Nextracker Inc. Investors are being informed about a recent class action lawsuit that has been initiated concerning Nextracker Inc. (NASDAQ: NXT). This case was filed on behalf of all individuals and entities who acquired shares of Nextracker’s common stock during a specified period. Nextracker, known for its innovative solar...

Continue Reading
Boba Mint Holdings Reports Significant Growth for Tanjea Game

Updated Category News Views 74

Boba Mint Holdings Celebrates Impressive Milestones in Gaming Boba Mint Holdings Ltd. (CSE: TNJ) recently announced outstanding milestones in user growth for its flagship blockchain mobile game, Tanjea. Following the last update on user downloads back in May, the company has reported that total downloads for Tanjea have now exceeded 409,670, with an impressive count of...

Continue Reading
Tixel i® Revolutionizes Dry Eye Treatment with Strong Results

Updated Category News Views 265

Tixel i® Revolutionizes Dry Eye Treatment A recent publication highlights the remarkable advancements Tixel i® has brought to the field of ophthalmology, particularly for patients dealing with Evaporative Dry Eye Disease (DED) linked to Meibomian Gland Dysfunction (MGD). This cutting-edge technology has gained recognition for its effectiveness in providing long-lasting...

Continue Reading
ClarityPay Enhances Leadership with MJ Panda as COO for Growth

Updated Category News Views 141

ClarityPay Enhances Leadership with MJ Panda as COO ClarityPay, a frontrunner in customized point-of-sale credit solutions, has appointed Mrutyunjaya "MJ" Panda as its new Chief Operating Officer. Panda brings with him an impressive background, having held significant roles at both Goldman Sachs and American Express, where he developed a wealth of knowledge in risk...

Continue Reading